Foreo FAQ 201 Ultra-Lightweight Silicone RGB LED Face Mask What it is: FAQ™ 201 Ultra-Lightweight Silicone RGB LED Face Mask quickly and effectively refines & combats signs of aging and marks a new era of beauty-tech wearables. The clinical strength of red, green & blue LED light therapy delivers skin-restoring, professional treatments right into your home. What it does: The innovative, translucent & bacteria-resistant optical silicone mimics facial contours with a flexi-fit feature, ensuring even light distribution of 600 strategically placed light replicators and maintaining the wavelength purity for superior efficacy every time. The hands-free, soft-fit FAQ™ 201 is a lightweight & wireless mask with an open-eye design, protecting the eyes from LED light and allowing free movement as you enjoy a pleasant, non-invasive light therapy treatment any time of day. Features and Benefits: • Red LED (650 nm) diminishes signs of aging for younger-looking skin • Green LED (519 nm) brightens & evens out dull skin tone • Blue LED (420 nm) reduces the appearance of imperfections • 600 points of light are optimized to ensure the LED wavelengths penetrate evenly across all areas of the skin. • Gentle heat warms the skin to temporarily dilate the pores allowing topical skincare to deeply penetrate the skin • Ultra-lightweight, extremely hygienic and wireless, with an open eye design and a non-slip headband to keep it in place while you move around. • Flexi-fit silicone molds to your face like a transparent second skin for complete freedom of movement • No replacement parts needed, ever • USB rechargeable. Up to 100 minutes per charge. • 2-year limited warranty Clinical Results: • Clinically proven to reduce blemishes by 48% and reduce excess sebum by 18% in just 2 weeks.* • 100% of users report skin tone is more even, with less sun spots** • 100% of users report reduced redness and soothed skin** * Based on 3rd party clinical testing with 30 female subjects, aged 20-45, over 28 days ** Based on 3rd party consumer testing with 30 female subjects, aged 20-45, over 28 days